These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19521082)

  • 1. Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment.
    Moreau T; Schmidt N; Joyeux O; Bungener C; Souvignet V
    Eur Neurol; 2009; 62(2):79-85. PubMed ID: 19521082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
    Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
    Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis.
    Giovannoni G; Barbarash O; Casset-Semanaz F; Jaber A; King J; Metz L; Pardo G; Simsarian J; Sørensen PS; Stubinski B;
    Clin Ther; 2007 Jun; 29(6):1128-45. PubMed ID: 17692727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
    Río J; Rovira A; Tintoré M; Huerga E; Nos C; Tellez N; Tur C; Comabella M; Montalban X
    Mult Scler; 2008 May; 14(4):479-84. PubMed ID: 18562504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis.
    Lode K; Bru E; Klevan G; Myhr KM; Nyland H; Larsen JP
    Mult Scler; 2009 May; 15(5):638-43. PubMed ID: 19299438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.
    Moreau T; Bungener C; Heinzlef O; Suchet L; Borgel F; Bourdeix I; Meite M; Rerat K; Chouette I;
    Eur Neurol; 2017; 77(1-2):47-55. PubMed ID: 27907914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personality features in multiple sclerosis patients with a relapsing-remitting course of the disease].
    Papuć E; Pawłowska B
    Psychiatr Pol; 2005; 39(4):669-78. PubMed ID: 16237972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study.
    Boz C; Oger J; Gibbs E; Grossberg SE;
    Mult Scler; 2007 Nov; 13(9):1127-37. PubMed ID: 17967840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
    Montel SR; Bungener C
    Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.
    Koch-Henriksen N; Sorensen PS; Bendtzen K; Flachs EM
    Mult Scler; 2009 May; 15(5):601-5. PubMed ID: 19299439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and anxiety during isolation and radionuclide therapy.
    Brans B; van den Eynde F; Audenaert K; Vervaet M; van Daele K; van Heeringen C; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):881-6. PubMed ID: 12869820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures in the first year of therapy predict the response to interferon beta in MS.
    Río J; Castilló J; Rovira A; Tintoré M; Sastre-Garriga J; Horga A; Nos C; Comabella M; Aymerich X; Montalbán X
    Mult Scler; 2009 Jul; 15(7):848-53. PubMed ID: 19542263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.
    Trojano M; Pellegrini F; Paolicelli D; Fuiani A; Zimatore GB; Tortorella C; Simone IL; Patti F; Ghezzi A; Zipoli V; Rossi P; Pozzilli C; Salemi G; Lugaresi A; Bergamaschi R; Millefiorini E; Clerico M; Lus G; Vianello M; Avolio C; Cavalla P; Lepore V; Livrea P; Comi G; Amato MP;
    Ann Neurol; 2009 Oct; 66(4):513-20. PubMed ID: 19847899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis and depression].
    Sánchez López MP; Olivares Pérez T; Nieto Barco A; Hernández Pérez MA; Barroso Ribal J
    Rev Neurol; 2004 Mar 16-31; 38(6):524-9. PubMed ID: 15054715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coping with severe burns in the early stage after burn injury.
    Bras M; Loncar Z; Brajković L; Gregurek R; Micković V
    Coll Antropol; 2007 Mar; 31(1):159-63. PubMed ID: 17598395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological state, quality of life, and coping style in patients with digestive cancer.
    Matsushita T; Matsushima E; Maruyama M
    Gen Hosp Psychiatry; 2005; 27(2):125-32. PubMed ID: 15763124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New natural history of interferon-beta-treated relapsing multiple sclerosis.
    Trojano M; Pellegrini F; Fuiani A; Paolicelli D; Zipoli V; Zimatore GB; Di Monte E; Portaccio E; Lepore V; Livrea P; Amato MP
    Ann Neurol; 2007 Apr; 61(4):300-6. PubMed ID: 17444502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible interactive effects of demographic factors and stress coping mechanisms on depression and anxiety in maintenance hemodialysis patients.
    Takaki J; Nishi T; Shimoyama H; Inada T; Matsuyama N; Kumano H; Kuboki T
    J Psychosom Res; 2005 Mar; 58(3):217-23. PubMed ID: 15865945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.
    Comabella M; Río J; Espejo C; Ruiz de Villa M; Al-Zayat H; Nos C; Deisenhammer F; Baranzini SE; Nonell L; López C; Julià E; Oksenberg JR; Montalban X
    Clin Immunol; 2009 Feb; 130(2):145-50. PubMed ID: 18945642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.